{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:50:30Z","timestamp":1791867030014,"version":"4.3.4"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["108877\/Z\/15\/Z"],"award-info":[{"award-number":["108877\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000313","name":"BSAC","doi-asserted-by":"publisher","award":["bsac-2019-0030"],"award-info":[{"award-number":["bsac-2019-0030"]}],"id":[{"id":"10.13039\/501100000313","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovative Medicines Initiative Joint Undertaking","award":["115337"],"award-info":[{"award-number":["115337"]}]},{"name":"European Union\u2019s Seventh Framework Programme","award":["FP7\/2007\u20132013"],"award-info":[{"award-number":["FP7\/2007\u20132013"]}]},{"DOI":"10.13039\/100013322","name":"EFPIA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The rise of antimicrobial drug resistance in Mycobacterium tuberculosis coupled with the shortage of new antibiotics has elevated TB to a major global health priority. Repurposing drugs developed or used for other conditions has gained special attention in the current scenario of accelerated drug development for several global infectious diseases. In a similar effort, previous studies revealed that carprofen, a non-steroidal anti-inflammatory drug, selectively inhibited the growth of replicating, non-replicating and MDR clinical isolates of M. tuberculosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>We aimed to reveal the whole-cell phenotypic and transcriptomic effects of carprofen in mycobacteria.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Integrative molecular and microbiological approaches such as resazurin microtitre plate assay, high-throughput spot-culture growth inhibition assay, whole-cell efflux inhibition, biofilm inhibition and microarray analyses were performed. Analogues of carprofen were also synthesized and assessed for their antimycobacterial activity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Carprofen was found to be a bactericidal drug that inhibited mycobacterial drug efflux mechanisms. It also restricted mycobacterial biofilm growth. Transcriptome profiling revealed that carprofen likely acts by targeting respiration through the disruption of membrane potential. The pleiotropic nature of carprofen\u2019s anti-TB action may explain why spontaneous drug-resistant mutants could not be isolated in practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This immunomodulatory drug and its chemical analogues have the potential to reverse TB antimicrobial drug resistance, offering a swift path to clinical trials of novel TB drug combinations.<\/jats:p><\/jats:sec>","DOI":"10.1093\/jac\/dkaa307","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T19:15:30Z","timestamp":1593026130000},"page":"3194-3201","source":"Crossref","is-referenced-by-count":24,"title":["Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis"],"prefix":"10.1093","volume":"75","author":[{"given":"Arundhati","family":"Maitra","sequence":"first","affiliation":[{"name":"Mycobacteria Research Laboratory, Institute of Structural and Molecular Biology, Department of Biological Sciences, Birkbeck, University of London, Malet Street, London WC1E 7HX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Evangelopoulos","sequence":"additional","affiliation":[{"name":"UCL Centre for Clinical Microbiology, University College London, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Chrzastek","sequence":"additional","affiliation":[{"name":"Mycobacteria Research Laboratory, Institute of Structural and Molecular Biology, Department of Biological Sciences, Birkbeck, University of London, Malet Street, London WC1E 7HX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam T","family":"Martin","sequence":"additional","affiliation":[{"name":"Mycobacteria Research Laboratory, Institute of Structural and Molecular Biology, Department of Biological Sciences, Birkbeck, University of London, Malet Street, London WC1E 7HX, UK"},{"name":"Department of Chemistry, University College London, 20 Gordon Street, London WC1H 0AJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"Hanrath","sequence":"additional","affiliation":[{"name":"UCL Centre for Clinical Microbiology, University College London, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie","family":"Chapman","sequence":"additional","affiliation":[{"name":"Mycobacteria Research Laboratory, Institute of Structural and Molecular Biology, Department of Biological Sciences, Birkbeck, University of London, Malet Street, London WC1E 7HX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen C","family":"Hailes","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University College London, 20 Gordon Street, London WC1H 0AJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lipman","sequence":"additional","affiliation":[{"name":"Royal Free London NHS Foundation Trust, UCL-TB and UCL Respiratory, University College London, London NW3 2QG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D","family":"McHugh","sequence":"additional","affiliation":[{"name":"UCL Centre for Clinical Microbiology, University College London, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J","family":"Waddell","sequence":"additional","affiliation":[{"name":"Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton BN1 9PX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1165-9295","authenticated-orcid":false,"given":"Sanjib","family":"Bhakta","sequence":"additional","affiliation":[{"name":"Mycobacteria Research Laboratory, Institute of Structural and Molecular Biology, Department of Biological Sciences, Birkbeck, University of London, Malet Street, London WC1E 7HX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"key":"2020101604552486200_dkaa307-B1","year":"2019"},{"key":"2020101604552486200_dkaa307-B2","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/jac\/dkr173","article-title":"Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs","volume":"66","author":"da Silva","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2020101604552486200_dkaa307-B3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijid.2014.12.031","article-title":"Repurposing a ray of hope in tackling extensively drug resistance in tuberculosis","volume":"32","author":"Maitra","year":"2015","journal-title":"Int J Infect Dis"},{"key":"2020101604552486200_dkaa307-B4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/bmb\/ldw019","article-title":"Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs","volume":"118","author":"Maitra","year":"2016","journal-title":"Br Med Bull"},{"key":"2020101604552486200_dkaa307-B5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrd4001","article-title":"Advances in the development of new tuberculosis drugs and treatment regimens","volume":"12","author":"Zumla","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"2020101604552486200_dkaa307-B6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jac\/dks405","article-title":"Is repositioning of drugs a viable alternative in the treatment of tuberculosis?","volume":"68","author":"Palomino","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2020101604552486200_dkaa307-B7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"2020101604552486200_dkaa307-B8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/infdis\/jit152","article-title":"Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis","volume":"208","author":"Vilaplana","year":"2013","journal-title":"J Infect Dis"},{"key":"2020101604552486200_dkaa307-B9","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3389\/fimmu.2018.00798","article-title":"A beneficial effect of low-dose aspirin in a murine model of active tuberculosis","volume":"9","author":"Kroesen","year":"2018","journal-title":"Front Immunol"},{"key":"2020101604552486200_dkaa307-B10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jac\/dkl486","article-title":"Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis","volume":"59","author":"Byrne","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"2020101604552486200_dkaa307-B11","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijantimicag.2007.04.016","article-title":"Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice","volume":"30","author":"Dutta","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"2020101604552486200_dkaa307-B12","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.3390\/molecules24234373","article-title":"A repurposing approach for uncovering the anti-tubercular activity of FDA-approved drugs with potential multi-targeting profiles","volume":"24","author":"Battah","year":"2019","journal-title":"Molecules"},{"key":"2020101604552486200_dkaa307-B13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s42003-019-0530-3","article-title":"Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice","volume":"2","author":"Mortensen","year":"2019","journal-title":"Commun Biol"},{"key":"2020101604552486200_dkaa307-B14","doi-asserted-by":"crossref","first-page":"13491","DOI":"10.1038\/s41598-018-31590-4","article-title":"Adjunctive use of celecoxib with anti-tuberculosis drugs: evaluation in a whole-blood bactericidal activity model","volume":"8","author":"Naftalin","year":"2018","journal-title":"Sci Rep"},{"key":"2020101604552486200_dkaa307-B15","doi-asserted-by":"crossref","first-page":"e002672","DOI":"10.1136\/bmjopen-2013-002672","article-title":"Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay","volume":"3","author":"Guzman","year":"2013","journal-title":"BMJ Open"},{"key":"2020101604552486200_dkaa307-B16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/vr.152.13.392","article-title":"Clinical efficacy of flunixin, carprofen and ketoprofen as adjuncts to the antibacterial treatment of bovine respiratory disease","volume":"152","author":"Lockwood","year":"2003","journal-title":"Vet Rec"},{"key":"2020101604552486200_dkaa307-B17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/ac60111a017","article-title":"Colorimetric method for determination of sugars and related substances","volume":"28","author":"Dubois","year":"1956","journal-title":"Anal Chem"},{"key":"2020101604552486200_dkaa307-B18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.tube.2003.12.005","article-title":"The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds","volume":"84","author":"Waddell","year":"2004","journal-title":"Tuberculosis"},{"key":"2020101604552486200_dkaa307-B19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1079\/9781845938079.0173","volume-title":"Tuberculosis: Laboratory Diagnosis and Treatment Strategies. CAB International","author":"Waddell","year":"2013"},{"key":"2020101604552486200_dkaa307-B20","doi-asserted-by":"crossref","first-page":"e1403","DOI":"10.1371\/journal.pone.0001403","article-title":"Probing host pathogen cross-talk by transcriptional profiling of both Mycobacterium tuberculosis and infected human dendritic cells and macrophages","volume":"3","author":"Tailleux","year":"2008","journal-title":"PLoS One"},{"key":"2020101604552486200_dkaa307-B21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-4939-7638-6_11","volume-title":"Antibiotic Resistance Protocols","author":"Wildner","year":"2018"},{"key":"2020101604552486200_dkaa307-B22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-60327-279-7_15","volume-title":"Antibiotic Resistance Protocols","author":"Evangelopoulos","year":"2010"},{"key":"2020101604552486200_dkaa307-B23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/9780471729259.mc1708s40","article-title":"HT-SPOTi: a rapid drug susceptibility test (DST) to evaluate antibiotic resistance profiles and novel chemicals for anti-infective drug discovery","volume":"40","author":"Danquah","year":"2016","journal-title":"Curr Protoc Microbiol"},{"key":"2020101604552486200_dkaa307-B24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1021\/acsinfecdis.9b00373","article-title":"Large-scale chemical-genetic strategy enables the design of antimicrobial combination chemotherapy in Mycobacteria","volume":"6","author":"Johnson","year":"2020","journal-title":"ACS Infect Dis"},{"key":"2020101604552486200_dkaa307-B25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1128\/mBio.02627-19","article-title":"Transcriptomic signatures predict regulators of drug synergy and clinical regimen efficacy against tuberculosis","volume":"10","author":"Ma","year":"2019","journal-title":"MBio"},{"key":"2020101604552486200_dkaa307-B26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/dkv316","article-title":"Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy","volume":"71","author":"Pule","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2020101604552486200_dkaa307-B27","doi-asserted-by":"crossref","first-page":"38915","DOI":"10.1074\/jbc.M206855200","article-title":"Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2","volume":"277","author":"Patel","year":"2002","journal-title":"J Biol Chem"},{"key":"2020101604552486200_dkaa307-B28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/AAC.00735-10","article-title":"Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor","volume":"55","author":"Kalle","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2020101604552486200_dkaa307-B29","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00280-009-1097-3","article-title":"Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line","volume":"65","author":"Roy","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"2020101604552486200_dkaa307-B30","doi-asserted-by":"crossref","first-page":"809014","DOI":"10.1155\/2015\/809014","article-title":"General overview on nontuberculous mycobacteria, biofilms, and human infection","volume":"2015","author":"Faria","year":"2015","journal-title":"J Pathog"},{"key":"2020101604552486200_dkaa307-B31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4161\/viru.23724","article-title":"Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm","volume":"4","author":"Soto","year":"2013","journal-title":"Virulence"},{"key":"2020101604552486200_dkaa307-B32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1128\/AAC.48.1.41-47.2004","article-title":"Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans","volume":"48","author":"Alem","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2020101604552486200_dkaa307-B33","doi-asserted-by":"crossref","first-page":"16004","DOI":"10.1073\/pnas.1214188109","article-title":"Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials","volume":"109","author":"Gold","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"2020101604552486200_dkaa307-B34","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1128\/AAC.47.9.2903-2913.2003","article-title":"Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis","volume":"47","author":"Betts","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2020101604552486200_dkaa307-B35","doi-asserted-by":"crossref","first-page":"e1502","DOI":"10.1371\/journal.pone.0001502","article-title":"The enduring hypoxic response of Mycobacterium tuberculosis","volume":"3","author":"Rustad","year":"2008","journal-title":"PLoS One"},{"key":"2020101604552486200_dkaa307-B36","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.tube.2004.02.003","article-title":"Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy","volume":"84","author":"Voskuil","year":"2004","journal-title":"Tuberculosis"},{"key":"2020101604552486200_dkaa307-B37","doi-asserted-by":"crossref","first-page":"140106","DOI":"10.1098\/rsob.140106","article-title":"Potassium availability triggers Mycobacterium tuberculosis transition to, and resuscitation from, non-culturable (dormant) states","volume":"4","author":"Salina","year":"2014","journal-title":"Open Biol"},{"key":"2020101604552486200_dkaa307-B38","doi-asserted-by":"crossref","first-page":"40174","DOI":"10.1074\/jbc.M406796200","article-title":"The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action","volume":"279","author":"Boshoff","year":"2004","journal-title":"J Biol Chem"},{"key":"2020101604552486200_dkaa307-B39","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1073\/pnas.74.6.2241","article-title":"Uncouplers and the molecular mechanism of uncoupling in mitochondria","volume":"74","author":"Kessler","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020101604552486200_dkaa307-B40","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.molmed.2005.06.006","article-title":"Inhibitors of efflux pumps in Gram-negative bacteria","volume":"11","author":"Pag\u00e8s","year":"2005","journal-title":"Trends Mol Med"},{"key":"2020101604552486200_dkaa307-B41","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.4155\/fmc.11.90","article-title":"Nitroimidazoles for the treatment of TB: past, present and future","volume":"3","author":"Mukherjee","year":"2011","journal-title":"Future Med Chem"},{"key":"2020101604552486200_dkaa307-B42","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1126\/science.1164571","article-title":"PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release","volume":"322","author":"Singh","year":"2008","journal-title":"Science"},{"key":"2020101604552486200_dkaa307-B43","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/anie.199513481","article-title":"A simple catalytic method for the conversion of aryl bromides to arylamines","volume":"34","author":"Guram","year":"1995","journal-title":"Angew Chem Int Ed Engl"},{"key":"2020101604552486200_dkaa307-B44","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1021\/ja901414u","article-title":"An efficient process for Pd-catalyzed C\u2212N cross-coupling reactions of aryl iodides: insight into controlling factors","volume":"131","author":"Fors","year":"2009","journal-title":"J Am Chem Soc"},{"key":"2020101604552486200_dkaa307-B45","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1016\/j.tet.2019.05.003","article-title":"Biaryl monophosphine ligands in palladium-catalyzed C\u2013N coupling: an updated user\u2019s guide","volume":"75","author":"Ingoglia","year":"2019","journal-title":"Tetrahedron"},{"key":"2020101604552486200_dkaa307-B46","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1021\/jo800596m","article-title":"Intramolecular Pd (II)-catalyzed oxidative biaryl synthesis under air: reaction development and scope","volume":"73","author":"Li\u00e9gault","year":"2008","journal-title":"J Org Chem"},{"key":"2020101604552486200_dkaa307-B47","author":"Gurien","year":"1979"},{"key":"2020101604552486200_dkaa307-B48","author":"Yi","year":"2017"},{"key":"2020101604552486200_dkaa307-B49","first-page":"488","article-title":"In vitro studies of anti-inflammatory activity of carprofen","volume":"5","author":"Tursi","year":"1982","journal-title":"Eur J Rheumatol Inflamm"},{"key":"2020101604552486200_dkaa307-B50","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41385-019-0195-8","article-title":"Neutrophils express pro-and anti-inflammatory cytokines in granulomas from Mycobacterium tuberculosis-infected cynomolgus macaques","volume":"12","author":"Gideon","year":"2019","journal-title":"Mucosal Immunol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/11\/3194\/33893146\/dkaa307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/11\/3194\/33893146\/dkaa307.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T17:25:06Z","timestamp":1616347506000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/75\/11\/3194\/5892302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,8,13]]},"published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaa307","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,8,13]]}}}